You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

N-methyl-D-aspartate receptor (NMDAR) antagonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Therapy of Anti-NMDAR Encephalitis at Diagnosis

Active, not recruiting
  • Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
    • Rotterdam, Netherlands
      Erasmus Medical Center
    Sep 4, 2023

    Psycho-social Impact of Anti-NMDAR Encephalitis

    Not yet recruiting
    • NMDAR Antibody-associated Auto-immune Encephalitis
    • standardized and validated surveys
    • Bron, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Jul 13, 2023

    Clinical-immunological Features of Anti-NMDAR Encephalitis

    Active, not recruiting
    • Anti NMDA Receptor Encephalitis
    • Description of clinical characteristic
    • Lyon, Bron, France
      Hôpital Neurologique Pierre Wertheimer / Groupement Hospitalier
    Feb 12, 2023

    Anti-NMDAR Encephalitis Trial in Paris (IA session, Rituximab)

    Recruiting
    • Anti-NMDAR Encephalitis
    • Paris, France
      Hôpital Necker Enfants-Malades
    Oct 31, 2022

    NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis Trial in Prague, Praha 5 (Satralizumab, Placebo)

    Not yet recruiting
    • NMDAR Autoimmune Encephalitis
    • LGI1 Autoimmune Encephalitis
    • Prague, Czechia
    • +1 more
    Aug 15, 2022

    Developing Advanced Neuroimaging for Clinical Evaluation of

    Recruiting
    • Anti-N-Methyl-D-Aspartate Receptor Encephalitis
    • Autoimmune Encephalitis
    • Not applicable - non-interventional study
    • London, Greater London, United Kingdom
      Guy's and St Thomas' NHS Foundation Trust
    Jun 14, 2022

    GWAS in NMDAR Encephalitis

    Recruiting
    • Autoimmune Encephalitis
    • GWAS
    • Lyon, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Feb 4, 2022

    Learning and Memory in Healthy Individuals and Those With Psychiatric Illness Trial in Chicago (GLYX-13, Placebo)

    Terminated
    • Learning and Memory in Healthy Individuals and Those With Psychiatric Illness
    • Chicago, Illinois
      Northwestern University
    Jan 14, 2022

    Diagnostic Score for Encephalitis to Assess Risk of Autoimmune

    Recruiting
    • Autoimmune Encephalitis
    • Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
    • Clinical score of Granillo and al.
    • Lyon, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Jul 12, 2023

    Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)

    Recruiting
    • Rotator Cuff Tendinitis
    • Chronic Pain
    • Kristiansund, Norway
      Department of Orthopedic Surgery, Kristiansund Hospital
    Mar 15, 2022

    Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)

    Not yet recruiting
    • Schizophrenia
    • Taichung, Taiwan
      Department of Psychiatry, China Medical University Hospital
    Sep 4, 2023

    Depressive Disorder, MDD, Bipolar Disorder Trial in West Haven (Perampanel 6 MG, Ketamine, Placebo)

    Not yet recruiting
    • Depressive Disorder
    • +4 more
    • Perampanel 6 MG
    • +2 more
    • West Haven, Connecticut
      VA Connecticut Healthcare System
    Mar 14, 2023

    Paraneoplastic Neurologic Encephalitis and Mature Cystic

    Recruiting
    • Ovarian Dermoid Cyst
    • Blood sample
    • Rishon LeZion, Israel
      Shamir medical center
    Jan 23, 2022

    Schizophrenia, Schizo Affective Disorder Trial in New York (D-serine, Placebo)

    Not yet recruiting
    • Schizophrenia
    • Schizo Affective Disorder
    • New York, New York
      New York State Psychiatric
    Jul 25, 2022

    MDD, Treatment-Resistant Depression, Depression Trial run by the NIMH (Placebo, TS-161 (50 - 100 mg))

    Recruiting
    • Major Depressive Disorder
    • +2 more
    • Placebo
    • TS-161 (50 - 100 mg)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Treatment Resistant Schizophrenia Trial in Bhubaneswar (Dextromethorphan, Placebo)

    Not yet recruiting
    • Treatment Resistant Schizophrenia
    • Bhubaneswar, Odisha, India
      All India Institute of Medical Sciences (AIIMS)
    Jul 15, 2023

    Preemptive Analgesia, Dexmedetomidine, Ketamine Trial in Kafr Ash Shaykh (Dexmedetomidine, Ketamine, Magnesium sulphate)

    Not yet recruiting
    • Preemptive Analgesia
    • +5 more
    • Kafr Ash Shaykh, Karelsheikh, Egypt
      Karelsheikh University Hospital
    Apr 19, 2023

    Magnesium, Intraoperative Analgesia Trial (Magnesium Sulfate, Propofol)

    Not yet recruiting
    • Magnesium
    • Intraoperative Analgesia
    • (no location specified)
    Nov 12, 2023

    Bipolar Depression, Bipolar Affective Disorder Trial (NRX-101)

    Available
    • Bipolar Depression
    • Bipolar Affective Disorder
    • (no location specified)
    Mar 22, 2023

    Postoperative Pain Trial in Denizli (Magnesium Sulfate, normal saline isotonic solution)

    Completed
    • Postoperative Pain
    • Magnesium Sulfate
    • normal saline isotonic solution
    • Denizli, Turkey
      Pamukkale Univercity Medical School
    May 25, 2023

    Optic Neuritis, Transverse Myelitis, Acute Disseminated Encephalomyelitis Trial in Switzerland

    Recruiting
    • Optic Neuritis
    • +16 more
      • Aarau, Aargau, Switzerland
      • +11 more
      Aug 18, 2021

      S-ketamine, Postoperative Analgesia, Spine Fusion Trial in Beijing (S-ketamine, Placebo)

      Recruiting
      • S-ketamine
      • +2 more
      • Beijing, Beijing, China
        Beijing University First Hospital
      Apr 19, 2022

      Emergence Agitation Trial in Shanghai (Esketamine, Sevoflurane)

      Recruiting
      • Emergence Agitation
      • Shanghai, Shanghai, China
        Anesthesiology Department of Affiliated Eye and ENT Hospital, Fu
      Dec 3, 2022

      Preoperative Ketamine Nebulization on Postoperative Sore Throat

      Not yet recruiting
      • Post Operative Sore Throat
      • (no location specified)
      Jul 27, 2023

      Refractory Epilepsy Trial in Birmingham (Traditional Treatment (Group T), Ketamine Infusion (Group K))

      Withdrawn
      • Refractory Epilepsy
      • Traditional Treatment (Group T)
      • Ketamine Infusion (Group K)
      • Birmingham, Alabama
        UAB Department of Anesthesiology and Perioperative Medicine
      May 18, 2021